Portfolio (Quarterly)
Guide ↗
Soleus Capital Management, L.P.
· CIK 0001802630| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CELC | CELCUITY INC | Healthcare | 1,284,378.0 | $146.6M | 5.94% | -524K | -29.0% | $114.14 | +21.1% |
| 2 | — | PRAXIS PRECISION MEDICINES I | — | 330,517.0 | $106.5M | 4.31% | -32K | -8.9% | $322.19 | — |
| 3 | — | GLOBUS MED INC | — | 729,467.0 | $62.9M | 2.54% | -158K | -17.8% | $86.16 | — |
| 4 | TWST | TWIST BIOSCIENCE CORP | Healthcare | 1,226,629.0 | $58.3M | 2.36% | -635K | -34.1% | $47.52 | +27.5% |
| 5 | SNDX | SYNDAX PHARMACEUTICALS INC | Healthcare | 1,726,908.0 | $40.3M | 1.63% | -520K | -23.1% | $23.36 | -14.6% |
| 6 | MIRM | MIRUM PHARMACEUTICALS INC | Healthcare | 400,306.0 | $37.0M | 1.50% | -173K | -30.2% | $92.38 | +6.8% |
| 7 | BMRN | BIOMARIN PHARMACEUTICAL INC | Healthcare | 650,572.0 | $36.8M | 1.49% | -669K | -50.7% | $56.49 | -4.2% |
| 8 | — | KINIKSA PHARMACEUTICALS INTL | — | 521,353.0 | $25.1M | 1.02% | -66K | -11.2% | $48.15 | — |
| 9 | AXGN | AXOGEN INC | Healthcare | 679,170.0 | $22.5M | 0.91% | -528K | -43.7% | $33.13 | +23.5% |
| 10 | PCVX | VAXCYTE INC | Healthcare | 385,472.0 | $22.4M | 0.91% | -223K | -36.7% | $58.11 | -18.6% |
| 11 | NRIX | NURIX THERAPEUTICS INC | Healthcare | 938,163.0 | $14.5M | 0.59% | -281K | -23.1% | $15.50 | +12.9% |
| 12 | RCUS | ARCUS BIOSCIENCES INC | Healthcare | 451,983.0 | $9.8M | 0.40% | -260K | -36.5% | $21.60 | +8.5% |
| 13 | ELVN | ENLIVEN THERAPEUTICS INC | Healthcare | 230,869.0 | $9.1M | 0.37% | -794K | -77.5% | $39.20 | +6.0% |
| 14 | DXCM | DEXCOM INC | Healthcare | 140,000.0 | $8.8M | 0.36% | -1.2M | -89.2% | $62.80 | +14.8% |
| 15 | SEPN | SEPTERNA INC | Healthcare | 275,000.0 | $6.6M | 0.27% | -108K | -28.3% | $24.03 | +18.0% |
| 16 | IMVT | IMMUNOVANT INC | Healthcare | 230,000.0 | $5.7M | 0.23% | -880K | -79.3% | $24.84 | +37.5% |
| 17 | MBX | MBX BIOSCIENCES INC | Healthcare | 178,897.0 | $5.3M | 0.22% | -230K | -56.2% | $29.85 | +6.7% |
| 18 | GPCR | STRUCTURE THERAPEUTICS INC | Healthcare | 80,000.0 | $3.9M | 0.16% | -10K | -11.1% | $48.20 | -18.7% |
| 19 | ARGX | ARGENX SE | Healthcare | 3,500.0 | $2.6M | 0.10% | -28K | -89.0% | $730.25 | +10.4% |
| 20 | — | INSPIREMD INC | — | 1,045,708.0 | $1.7M | 0.07% | -104K | -9.1% | $1.63 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%